Glycosylated haemoglobin and glycosylated serum protein concentrations (fructosamine) have been monitored in patients suspected of diabetes mellitus (n= 183), in pregnant women suspected of gestational diabetes (n=250) and in control groups (n= 184). The response to the standard 75 g oral glucose tolerance test was used to confirm or reject the diagnosis, using different criteria for detection of diabetes mellitus compared to detection of gestational diabetes. A slightly higher sensitivity was observed for fructosamine compared to glycosylated haemoglobin to detect impaired glucose tolerance (52 vs 44%) or gestational diabetes (17% vs 8%). For detection of diabetic oral glucose tolerance no difference was observed between glycosylated haemoglobin and fructosamine; sensitivity for both parameters was 67%. The results suggest that fructosamine is slightly more sensitive in detecting borderline-abnormal glucose tolerance, whereas no differences are observed for detection of clearly abnormal oral glucose tolerance tests.
SUMMARY. Glycosylated haemoglobin and glycosylated serum protein concentrations (fructosamine) have been monitored in patients suspected of diabetes mellitus (n= 183), in pregnant women suspected of gestational diabetes (n=250) and in control groups (n= 184). The response to the standard 75 g oral glucose tolerance test was used to confirm or reject the diagnosis, using different criteria for detection of diabetes mellitus compared to detection of gestational diabetes. A slightly higher sensitivity was observed for fructosamine compared to glycosylated haemoglobin to detect impaired glucose tolerance (52 vs 44%) or gestational diabetes (17% vs 8%). For detection of diabetic oral glucose tolerance no difference was observed between glycosylated haemoglobin and fructosamine; sensitivity for both parameters was 67%. The results suggest that fructosamine is slightly more sensitive in detecting borderline-abnormal glucose tolerance, whereas no differences are observed for detection of clearly abnormal oral glucose tolerance tests.
Measurement of glycosylated haemoglobin (HbA I ) is considered as a useful parameter for assessing long-term glycaemic control of patients with diabetes mellitus. There is an acceptable correlation between the HbA I concentration and the degree of hyperglycaemia, i.e. the mean plasma glucose concentration during a period of 4-12 weeks prior to testing. I. 2 Glycosylated haemoglobin has been compared with the oral glucose tolerance test (OGTT) as a diagnostic test, but differences in administered dose of glucose and interpretation of results makes comparison difficult. 1.3.4.5 Recently an automated colorimetric method has been developed to measure the concentration of glycosylated serum proteins (fructosamine), predominantly glycosylated albumin.?: 7 Its measurement is an index of intermediate term blood glucose concentration (2-4 weeks) and has been suggested as a screening test for gestational diabetes": <) and for diabetes mellitus.?: 10 tional age on serum fructosamine and HbA I concentrations was examined.P Although a statistically significant decrease in both parameters was observed during pregnancy, it was too small to be of clinical significance.12 • From fructosamine measurements in hospitalised and non-hospitalised patients a significant influence of changing albumin concentrations on the fructosamine concentrations has been observed. However, only for very low albumin concentrations should a correction be made.!' It has been suggested that the fructosamine test is more sensitive for the detection of minor glucose intolerance than the HbA I test." ') Therefore, in the present investigation sensitivities of both parameters to detect either gestational diabetes (where more subtle changes have to be registered) or type I and type II diabetes mellitus (where a less sensitive parameter will be sufficient) have been compared. The response to the standard 75 g OGTT, using different criteria for gestational diabetes compared to type I or type II diabetes, has been used to confirm or reject the diagnosis. It is well known that there are many problems inherent to the OGTT,I. 4.5.14 especially for the diagnosis of gestational dia-betes,15. 16 and for the diagnosis of borderline diabetes mellitus." Nevertheless, as a better alternative is lacking, the OGrr has been used as a standard to determine the presence of glucose intolerance in different patient groups. Moreover, receiver operating characteristic curves, ROC-curves l7 were constructed to determine optimal sensitivity and specificity for the different tests at different cut-off values.
Patients and methods

PATIENTS
Patients suspected of having diabetes mellitus
A group of 183 patients suspected of having diabetes mellitus were referred to the clinical pathology department by their general practitioners for performance of an OGrr.
Pregnant women suspected of gestational diabetes
A group of 250 pregnant women attending the obstetric department of the De Wever Hospital in Heerlen for prenatal control, had an OGrr to confirm or reject glucose intolerance. Gestational age at time of OGrr varied from 5 to 41 weeks amenorrhoea.
Control groups
Pregnant controls. A group of 88 pregnant women attending the same obstetric department with no suspicion of gestational diabetes (gestational age 5~2 weeks) and having fasting glucose concentrations below 5·5 mmoVL.
Non-diabetic controls. A group of 96 nonhospitalised persons with no indication of diabetes mellitus and fasting glucose concentrations below 5·5 mmoVL.
A group of53 hospitalised non-diabetic patients (fasting glucose <5·5 mmoVL) with very low albumin concentrations were investigated in order to examine the influenee of low albumin concentrations and the effect of correction to a standard albumin concentration.
METHODS
Oral glucose tolerance test (OGTT)
Patients were told to take a normal diet for 3 days before the test. The oral glucose tolerance test was performed after an overnight fast.
Each patient was given an oral dose of 75 g of glucose. Glucose was measured in a fasting blood sample and in five samples obtained 30, 60,90, 120 and 180 min after the oral intake of glucose. An OGrr curve was drawn.
Criteria for the detection of diabetes mellitus.
Using the WHO criteria for the interpretation of glucose tolerance tests, the patients were divided into three groups, i.c, normal glucose tolerance, impaired glucose tolerance or diabetes mellitus." Normal curve: fasting glucose below 5·5 mmoVL. Impaired curve: fasting glucose below 8·0 mmol/L and glucose 120 min after oral intake of 75 g glucose between 8·0 and 11·0 mmoVL Diahetic curve: fasting glucose above 8·0 mmoVL and/or glucose 120 min after oral administration of glucose above 11·0 mmoVL.
Criteria for the detection of gestational diabetes. Criteria used were ohtained from the British Diabetic Association III and modified slightly. Normal curve: glucose values should not exceed 5·5 mmoVL for the fasting sample and 9·0, 9·0, 7,5, 6·5, and 5·5 mmol/L respectively at 30. 60. 90. 120and 180 min after oral glucose intake. Delayed curve: two out of the last three values exceed the value of the normal curve. Pre-diabetic curve: two out of the last three glucose levels exceed the normal level and the highest level exceeds 9·0 mmol/L. Diabetic curve: Two out of the last three glucose levels exceed the normal level, the highest level exceeds 9·0 mmol/L and the fasting level exceeds 5·5 mmol/L. Gestational diabetes was supposed to he present for patients with a pre-diabetic or a diabetic curve. No clinical significance was attached to a delayed curve. Patients with a pre-diabetic or diabetic curve were treated with a diet or with diet plus insulin administration.
The area under the OGTT-curve. This was computed with the Simpson method.
Blood for glucose measurements was collected by venepuncture into tubes containing fluoride and oxalate. Immediately after centrifugation at 3000 rpm for 5 min. all plasma samples were analysed on a Cobas Bio Centrifugal analyser using the Gluco-quanre glucose test combination (Boehringer. Mannheim, Germany; product no. 245178) based on the hexokinase/ glucose-o-phosphate dehydrogenase reaction. Blood for fructosamine, IlhA I and albumin determinations was taken at the same time as the fasting blood glucose samples. Serum for fructosamine, albumin and total protein determinations was stored at -20°C until analysed.
The fructosamine assay. (Roche Diagnostics Basel, Switzerland; product no. 0711217).
This was performed according to the method ofJohnson, Metcalfand Baker.6The test is based on the non-enzymatic formation of fructosamine fromglucose and proteins,whichcan be measured by nitro blue tetrazolium reduction. Serum sampleswere analysedon aCobas Biocentrifugal fastanalyserwith instrument setting as described by Roche. Intra-run precision 0·5-1·5% and inter-run precision 1,7-3·8%.
Serum albumin
This was analysed on a Cobas Bio centrifugal fast analyser. using Bromocresol green (Electro-Nucleonics, Fairfield USA) as a reagent.
Glycosylated haemoglobin
For the determination of glycosylated haemoglobin. 5 mL blood were collected in tubes containing K3H.EDTA and the haemoglobin-A. column test (Biorad, Richmond USA; product no. 19717(01), intra-run precision 2-4%, inter-run precision 5-6'Yo. was used.
Statistical analysis
Correlations were determined by linear regression analysis with the least squares method. Table 1 summarises the results obtained from Value of HbA I and fructosamine 449 patients suspected of having diabetes mellitus and from the non-diabetic control groups in whom diabetes mellitus was excluded (fasting glucose below 5·5 mmoUL). It can be concluded that for the OGTT group (non-hospitalised) and for the non-hospitalised control group correction of fructosamine to a standard albumin concentration 1.1 gave no improvement of the results. because no significant differences in albumin concentrations were observed between these groups. However, for the hospitalised patients with low albumin concentrations (n=53), correction of fructosamine values to a standard albumin concentration was necessary ( Table 1 ). After correction the mean fructosamine concentration of the non-diabetic hospitalised patients corresponded to the reference value for fructosamine as obtained from the non-hospitalised controls. Table 1 .
Results
PATIENTS SUSPECTED OF DIABETES MELLI-TUS
ROC-CURVE
A Receiver Operating Characteristic curve was constructed to evaluate and compare the usefulness of HbA I and fructosamine as a predictive test for impaired and/or diabetic OGTT ( Fig.) . ROC-curves are graphical presentations of sensitivity plotted against specificity'? for different cut-off values to determine positivity of fructosamine or HbA. values. The optimum portion of the ROC-curve is in the upper right comer of the graph shown in Fig. At the different cut-off values only small differences between HbA I and fructosamine could be observed.
In Table 2 Sensitivity impaired andlor diabetic OOTI are given at cut-off values for fructosamine >2·50 mmol/L) and for HbA I (>8·6%) as obtained from the control group, mean + 2SD. A higher sensitivity was observed for fructosamine (52%) compared to HbA I (44%), although larger groups should be investigated to make this small difference significant.
For the prediction of clearly diabetic OOTI's no differences between HbA I and fructosamine became apparent, sensitivity for both groups being 67%.
The diagnostic sensitivity of the fasting glucose concentration is high, but a large number of false-positives are observed, resulting in a low positive predictive value for an abnormal OOTI. HbA. (e e e). Sensitivity versus specificity of fructosaminc and HbA, for the prediction impaired or diabetic OGTI's, using different cutoff values for both parameters. Table 4 shows the sensitivity of HbA I and fructosamine in predicting an abnormal OGTT in patients suspected of gestational diabetes. Cut-off values for HbA, (>7·8%) and fructosamine (>2·30.mmoUL) were calculated from the control group (mean+2SD, n=88). The sensitivity of HbA, and fructosamine for predicting an abnormal OGTT in gestational diabetes is very low. This is to be expected when one takes into account that gestational diabetes is a very mild form of glucose intolerance compared to diabetes mellitus. The result is a large number of false-postive OGTT's in gestational diabetes.
PATIENTS SUSPECTED OF GESTATIONAL DIABETES
Discussion
DIABETES MELLITUS
For many years, diagnosis of diabetes has depended primarily on results of oral glucose loading tests. An OGTT is not necessary and diabetes mellitus is supposed to be present when the fasting glucose concentration is above 8 mmol/L. Fasting hyperglycaemia is not useful for evaluating the presence or severity of borderline glucose intolerance. However, for both the fasting glucose and for the OGTT too many false-positives are found.'?: 211 Determination of HbA I has been suggested as a more logical approach for the diagnosis of diabetes than measurement of plasma glucose during fasting." Increase of HbA I or fructosamine values implies abnormal glucose tolerance, but abnormal glucose tolerance does not necessarily imply increased HbA I or fructosamine levels. Prom our results, fructosamine appears to be more sensitive for. the detection of borderline glucose intolerance than does HbA I' For the prediction of clearly diabetic
Value of HbA I and fructosamine 451
OGTT's no difference has been observed between HbA I and fructosamine.
GESTATIONAL DIABETES
Gestational diabetes is defined as a mild form of glucose intolerance manifesting itself during pregnancy." In most cases this intolerance is only subclinically present. The clinical relevance and need to diagnose gestational diabetes and strictly control glucose levels during pregnancy, becomes apparent from studies which indicate an increased perinatal morbidity (macrosomia, neonatal hypoglycaemia and hyperbilirubinaemia) in children from patients suffering from gestational diabetes. 15. 16. 21-24 More convenient alternatives like the lunchtest, breakfast-test, day-curve and glucose measurement 1 h after 50 g glucose administration have been suggested. The OGTT is nevertheless, for want of a better alternative, still considered as the best method for detecting gestational diabetes.P Reference. valu~~for a normal OGTT and criteria used to confirm or reject the diagnosis differ throughout the literature, making comrarison of the investigations difficult. 15. 16. 21. 2•• 25. 26 However, it should be realised that physiological, pathological and drug interferences may occur, causing only moderate reproducibility of the abnormal OGTT. Coelingh-Bennink'P stated that the diagnosis of gestational diabetes can only be made by repeated abnormal OGTT, to eliminate the large number of falsepositives.
From the present study, it appears that fructosamine is slightly more sensitive for the detection of mild glucose intolerance in patients suspected of diabetes mellitus than HbA I . For patients suspected of gestational diabetes a higher, but still rather low sensitivity was observed for predicting abnormal OGTT's. Suitability of the test in gestational diabetes can however only be obtained when relating the fructosamine to foetal outcome in a large population of pregnant women. From the present study it appears that results for HbA I and fructosamine are at least comparable. Apart from the observed, slightly higher sensitivity, the fructosamine assay is easier to perform, precise, inexpensive and can easily be automated making it more suitable as a screening parameter for gestational diabetes or diabetes mellitus.
Moreover, intra-individual repeated measurements of fructosamine concentration during pregnancy might well enhance the sensi-tivity of the test. This is currently under investigation by us.
